IA
GILD icon

IFP Advisors’s Gilead Sciences GILD Stock Holding History

IFP Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
8,347
+1,254
+18% +$165K 0.02% 714
2026
Q1 		$989K Sell
7,093
-3,046
-30% -$427K 0.02% 697
2025
Q4 		$1.24M Sell
10,139
-864
-8% -$105K 0.03% 571
2025
Q3 		$1.22M Buy
11,003
+4,258
+63% +$484K 0.03% 527
2025
Q2 		$748K Sell
6,745
-6,376
-49% -$679K 0.02% 677
2025
Q1 		$1.47M Sell
13,121
-209
-2% -$21.6K 0.05% 446
2024
Q4 		$1.23M Buy
13,330
+7,919
+146% +$713K 0.04% 477
2024
Q3 		$454K Sell
5,411
-1,772
-25% -$135K 0.02% 727
2024
Q2 		$493K Sell
7,183
-3,049
-30% -$203K 0.02% 662
2024
Q1 		$749K Buy
10,232
+723
+8% +$55.6K 0.03% 487
2023
Q4 		$770K Buy
9,509
+634
+7% +$49.3K 0.04% 457
2023
Q3 		$665K Sell
8,875
-2,305
-21% -$177K 0.03% 502
2023
Q2 		$862K Sell
11,180
-1,617
-13% -$129K 0.04% 472
2023
Q1 		$1.14M Sell
12,797
-35,557
-74% -$2.95M 0.05% 348
2022
Q4 		$4.36M Sell
48,354
-5,208
-10% -$412K 0.12% 170
2022
Q3 		$4.83M Buy
53,562
+5,437
+11% +$343K 0.13% 166
2022
Q2 		$4.34M Hold
48,125
– – 0.14% 159
2022
Q1 		$4.34M Buy
48,125
+23,166
+93% +$1.48M 0.14% 159
2021
Q4 		$1.85M Buy
24,959
+15,715
+170% +$1.08M 0.04% 289
2021
Q3 		$645K Buy
9,244
+390
+4% +$27.4K 0.01% 513
2021
Q2 		$607K Buy
8,854
+2,289
+35% +$153K 0.01% 495
2021
Q1 		$423K Sell
6,565
-3,824
-37% -$247K 0.01% 575
2020
Q4 		$608K Sell
10,389
-705
-6% -$42.5K 0.02% 449
2020
Q3 		$706K Sell
11,094
-845
-7% -$58.6K 0.04% 355
2020
Q2 		$886K Buy
11,939
+2,005
+20% +$154K 0.07% 293
2020
Q1 		$737K Buy
9,934
+4,801
+94% +$332K 0.07% 268
2019
Q4 		$340K Sell
5,133
-5,159
-50% -$336K 0.03% 514
2019
Q3 		$654K Buy
+10,292
New +$673K 0.04% 419
2019
Q1 		$438K Sell
6,665
-10,785
-62% -$717K 0.06% 304
2018
Q4 		$1.08M Sell
17,450
-4,452
-20% -$311K 0.07% 334
2018
Q3 		$1.69M Sell
21,902
-1,251
-5% -$94.5K 0.07% 295
2018
Q2 		$1.64M Sell
23,153
-3,668
-14% -$259K 0.07% 292
2018
Q1 		$1.92M Hold
26,821
– – 0.09% 239
2017
Q4 		$1.92M Sell
26,821
-9,550
-26% -$725K 0.09% 240
2017
Q3 		$2.95M Buy
36,371
+2,884
+9% +$221K 0.12% 190
2017
Q2 		$2.37M Buy
33,487
+5,144
+18% +$342K 0.1% 223
2017
Q1 		$1.93M Sell
28,343
-741
-3% -$52.1K 0.08% 265
2016
Q4 		$2.08M Sell
29,084
-1,022
-3% -$76K 0.1% 218
2016
Q3 		$2.38M Buy
30,106
+1,755
+6% +$143K 0.12% 182
2016
Q2 		$2.37M Buy
28,351
+21,686
+325% +$1.92M 0.13% 165
2016
Q1 		$438K Sell
6,665
-23,283
-78% -$2.1M 0.06% 304
2015
Q4 		$3.03M Buy
+29,948
New +$3.12M 0.2% 106

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFP Advisors's GILD Position: Q2 2026 in Review

IFP Advisors increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $165K and bringing the position to 8,347 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #714.

IFP Advisors first reported a position in GILD in Q4 2015 and has held it in 42 quarters since. The position peaked at $4.83M in Q3 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IFP Advisors held 8,347 shares of Gilead Sciences worth $1.05M as of Q2 2026.
  • IFP Advisors bought 1,254 Gilead Sciences shares in Q2 2026, an estimated $165K.
  • Gilead Sciences made up 0.02% of IFP Advisors's portfolio in Q2 2026, its #714 holding.
  • IFP Advisors first reported a position in Gilead Sciences in Q4 2015 and has held it in 42 quarters since.
  • IFP Advisors's Gilead Sciences position peaked at $4.83M in Q3 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.